Label snapshot
What the product contains and what one serving costs, according to our catalog. Label amounts are not personal dose recommendations.
| Ingredient | Amount per serving |
|---|---|
| Alpha-Lipoic Acid | 100 mg |
| Quercetin | 50 mg |
Amounts are per label serving as recorded in the catalog and are not a recommendation. Testing status reflects what the brand lists. Nothing here is medical advice.
These calculations describe our scoring method. They are not a recommended dose or proof of benefit from this product.
Evidence gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Safety caps applied after weighting.
This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.
This Nuchido TIME+ scores 5.1, making it among the lowest-scoring products we track. It delivers 100mg of Alpha-Lipoic Acid, 33% of the studied range low edge (300mg) with grade A evidence (strong human trial data). At $13.00/day it's among the more expensive options in NAD+ booster.
The science behind each active ingredient, independent of which brand sells it.
Mitochondrial cofactor with genuine efficacy in diabetic neuropathy.
Best-studied 'senolytic' ingredient, though evidence is early.
Every active in this formula, its declared dose per serving, the dose used in the primary human trial, how much of that trial dose this product delivers, and the evidence grade for the ingredient itself.
| Ingredient | Dose / serving | Research dose | % of research | Evidence grade |
|---|---|---|---|---|
| Alpha-Lipoic Acid | 100 mg | 600 mg | 17% | A |
| Quercetin | 50 mg | 500 mg | 10% | B |
Percentages are dose per serving ÷ primary trial dose. Below 50% means the formula is unlikely to reproduce the trial outcome for that active. Grade A = multiple large human RCTs. Grade F = no human evidence. How grades work. Full glossary →
The specific product: dose, price, transparency, and what buyers report.
Safety flags, transparency gaps, dosing concerns, and recurring buyer complaints.
The main ingredients of this product, in plain language.
Mitochondrial cofactor with genuine efficacy in diabetic neuropathy.
Read about Alpha-Lipoic Acid →Best-studied 'senolytic' ingredient, though evidence is early.
Read about Quercetin →Hard numbers and independently checked status. Expand each block for its source.
All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Evidence grades are reviewed when new human RCTs are published. Read how we verify.
4.9 out of 5 across 21 verified reviews on 2 platforms.
Medium confidenceAuto-gathered from public review platforms via pplx_sdk fetch.
14 reviews · 4.7/5 · positive sentiment
These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.
No external reviews aggregated yet for this product.
Published evidence, claim checks, regulatory status and what could not be verified.
The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.
Developed by longevity scientist Dr. Nichola Conlon; unlike precursor-based products, targets root causes of NAD+ decline via a multi-ingredient enzyme-support formula. Clinical testing reported a 242% rise in cellular NAD+ within 16 days.
If you are the manufacturer or brand owner of TIME+ and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.
We review every request, verify it against primary sources, and publish any accepted change with a dated note. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.
Request a correction →The next highest-scoring products in NAD+ booster, same scoring method, same rules.
Renue By ScienceStatus as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.
Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.
DoNotAgeStatus as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.
Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.
Nootropics DepotStatus as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.
Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.
